<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36891">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01987921</url>
  </required_header>
  <id_info>
    <org_study_id>Pediatric AWARE Study</org_study_id>
    <nct_id>NCT01987921</nct_id>
  </id_info>
  <brief_title>Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes</brief_title>
  <acronym>AWARE</acronym>
  <official_title>Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric acute kidney injury (AKI) is associated with increased morbidity and mortality in
      critically ill patients. Currently, understanding of the epidemiology and diagnosis of AKI
      in children is limited by single center retrospective data and inconsistent diagnostic and
      stratification criteria. The hypotheses of the AWARE study is that 1) renal angina, a
      composite of early injury signs and risk of disease, will predict severe subsequent AKI in
      critically ill children and 2) the incorporation of urinary biomarkers into the renal angina
      scoring system will improve the prediction of the severe injury. The multi-center,
      multi-national registry will create the largest ever repository of information available on
      AKI in children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The AWARE study is a multicenter prospective observational study designed to achieve the
      following three goals:

        1. Establish the first international pediatric AKI registry to describe in detail the
           epidemiology and outcome of AKI in different pediatric and cardiac ICUs around the
           world.

        2. Validate the precision of RAI in ruling out AKI in a large, heterogeneous study
           population.

        3. Evaluate the predictive value of using RAI before and after the incorporation of four
           different urinary AKI biomarkers used in different combinations.

      To achieve these primary goals, children admitted to PICUs and/or pediatric cardiac ICUs
      from different US and international centers will be screened for enrollment eligibility.
      Patients admitted to general PICU and non-surgical patients admitted to cardiac ICUs are
      considered the target population of AWARE. Patients admitted to neonatal ICUs and
      post-surgical admissions to cardiac ICUs are not included in AWARE. Both clinical variables
      and urinary biomarkers would be needed to accomplish the analysis.

      A- Clinical variables: Clinical data of interest at study entry will include age, gender,
      race, ethnicity, height, weight, date of ICU admission, date of ICU discharge, date of
      hospital discharge, admission diagnosis(es) and primary co-morbidities. Creatinine clearance
      (eCrCl) will be estimated by the modified Schwartz formula29. Baseline creatinine will be
      collected if the patient had a listed value in the medical record in the 90 days prior to
      admission, with the lowest value selected if multiple measurements are present.  In cases
      where no baseline data is available, reference eCrCl will be estimated as 120 mL/min/1.73m2.
      30

      Clinical data will be recorded on admission and on a daily basis for the first seven days of
      the PICU admission or till discharge from the PICU whatever is earlier. Another set of data
      will be collected to evaluate the primary and secondary outcomes of the study (see later).
      The outcomes data will be collected on day 28 after ICU admission when available or by most
      recent available data before hospital discharge for patients with no available data on day
      28.

      Clinical parameters of interest include:

        -  use of fluid resuscitation in peri-ICU period ( normal saline, PlasmalyteTM ,Ringer's
           Lactate, 5% Albumin, starch based fluids including dextran composites)

        -  daily first shift heart rate (beats per minute) from day 1 through day 7 (at the most)
           of ICU admission

        -  daily first shift respiratory rate (breaths per minute) from day 1 through day 7 (at
           the most) of ICU admission

        -  daily first shift systolic and diastolic blood pressure and mean arterial pressure
           (arterial line measurements will be used when available) from day 1 through day 7 (at
           the most) of ICU admission

        -  daily first shift temperature from day 1 through day 7 (at the most) of ICU admission

        -  use of mechanical ventilation (yes/no)

        -  daily first shift mean airway pressure when applicable from day 1 through day 7 (at the
           most) of ICU admission

        -  duration of mechanical ventilation

        -  daily first shift oxygen blood saturation ( SpO2) from day 1 through day 7 (at the
           most) of ICU admission

        -  daily first shift fraction of inspired oxygen (FiO2) (%) from day 1 through day 7 (at
           the most) of ICU admission

        -  use of nephrotoxins (yes/no) from day 0 through day 7 (at the most) of ICU admission

        -  types of nephrotoxic agents:

           o Nonsteroidal anti-inflammatory drugs (NSAIDS)

             -  Aminoglycosides,

             -  anti-viral therapy,

             -  Vancomycin,

             -  Piperacillin/Tazobactam,

             -  Calcineurin inhibitors,

             -  IV radio-contrasts ( Including Gadolinium for MRI)

        -  use of inotropy (yes/no) from day 0 through day 7 (at the most) of ICU admission

        -  use of diuretics on day 0 and during admission (yes/no)

        -  class of diuretics used (Loop diuretics, Thiazides, Potassium sparing, Carbonic
           anhydrase inhibitors, Vasopressin antagonist, Osmotic diuretic,)

        -  serum creatinine (SCr) (mg/dl) from 3 months prior to ICU admission through up 28 days
           after admission

        -  fraction of inspired oxygen (FiO2) (%) from day 1 through day 7 (at the most) of ICU
           admission

        -  total fluid in (mL) from day 0 through day 7 (at the most of ICU admission)

        -  total fluid out (mL) from day 0 through day 7 (at the most of ICU admission)

        -  total urine output (mL) from day 0 through day 7 (at the most of ICU admission)

        -  urine output per 12-hour shift (mL/hr) from day 0 through day 7 (at the most of ICU
           admission)

        -  use of renal replacement therapy (RRT) (yes/no)

        -  modality of RRT when available

        -  use of ventricular assisted devices or extracorporeal Membrane Oxygenation (ECMO)

        -  outcome data

             -  mortality

             -  PICU length of stay

             -  hospital length of stay

      Calculated daily values include:

        -  % change in estimated creatinine clearance

             -  calculated as = Daily eCrCl - Baseline eCrCl) / (Baseline eCrCl) *100

        -  AKI stage per Kidney Disease Improving Global Outcomes (KDIGO) guidelines

           o Stages 1,2 ,3 assessed by both creatinine and urine output (Table-1)31

           o % Fluid overload: cumulative PICU fluid overload percentage (% FO), calculated as =
           ((total PICU Fluid in (L) - total PICU fluid out (L)) / PICU admit weight (kg))*100

        -  urine output per kg per 8 hour interval

        -  Renal angina index (RAI) will be assessed on Days 0 and 1.

             -  RAI will be derived as a composite of risk strata and clinical injury signs of
                AKI.

             -  Risk strata and risk scores of AKI:

      o

      1 (moderate risk): This stratum include all patients admitted to PICU and not fulfilling the
      criteria of high risk or very high risk strata 3 (high risk): This include all patients with
      history of solid organ or bone marrow transplantation ( BMT) 5 (very high risk): This
      include all patients who are BOTH intubated AND on an inotropy medication.

      AKI risk strata definitions and risk scores of children admitted to PICUs Patients
       Risk          Risk Score Any PICU admission    Moderate             1 History of BMT
          High                     3 Ventilated and Inotropy    Very high             5

      Clinical renal injury signs and injury scores of AKI are:

      1 (ICU status and no decrease in estimated creatinine clearance (eCrCl) or &lt;5% fluid
      overload FO) 2 (&gt; 5% FO or eCrCl decrease of 0-24.99%) 4 (&gt;10% FO or eCrCl decrease of
      25-49.99%) 8 (&gt;15% FO or eCrCl decrease of &gt; 50%).

      Clinical injury signs definition and injury scores of children admitted to PICU Injury by
      fluid overload (FO) Injury by decreased eCrCl  Injury score &lt; 5%
          No change              1 5 to &lt;10%                     Decreased by 0-24%              2
      10 to &lt; 15%                     Decreased by 25 - 49%      4

      ≥ 15%                             Decreased by ≥ 50%              8

      RAI = Risk score X Injury Score The range of indices is therefore: 1, 2, 3, 4, 5, 6, 8, 10,
      12, 20, 24, and 40. RAI &gt;= 8 indicates fulfillment of renal angina ( Basu et al5)

      Urine samples: The collection of urine samples is optional for the participating sites. The
      urine samples will be collected in the morning between 6 and 10 A.M. and/or in the afternoon
      between 3 and 7 P.M. for up to four days (day 0 through day 3) on all enrolled patients.
      Some centers may collect daily urine samples, others may choose to collect samples in both
      time windows. Urine will be drained only from the collection apparatus of an indwelling
      urinary drainage system or intermittent catheterization. Patients will not be bagged or
      catheterized separately/independently for the purposes of this study. Collected urine
      samples will be kept on ice or in 4° C refrigerator until they are processed. During
      processing, specimens will be centrifuged at 3000 RPM at 4°C for fifteen minutes. The
      supernatant will then be divided into up to nine 1-mL cryovials depending on the collected
      urine volume and stored at minus 80°C. The stored urine samples from all participating sites
      will be shipped to the Center for Acute Care Nephrology Biomarker Core Laboratory in the
      Division of Nephrology and Hypertension at Cincinnati Children's Hospital Medical Center
      when the coordinating site request the samples to be shipped at the time point set forth by
      the coordinating site. The shipping supplies and instructions will be provided by the
      coordinating site.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>28 Days</target_duration>
  <primary_outcome>
    <measure>Day 3 - AKI</measure>
    <time_frame>Day 3</time_frame>
    <safety_issue>No</safety_issue>
    <description>AKI as defined by KDIGO stage 2 or 3 assessed 72-96 hours after time of renal angina assessment (which is generally within 12-18 hours of admission to the pediatric intensive care unit)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of renal angina for AKI</measure>
    <time_frame>3-4 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess the predictive performance and operative characteristics of the renal angina index for the development of Day 3- AKI (defined in primary outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidities in the ICU</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Secondary outcomes include ICU length of stay, use of renal replacement therapy, use of extracorporeal support, and mortality.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Biomarker incorporation into renal angina index</measure>
    <time_frame>3-4 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Incorporating values of measured urinary biomarkers, we will determine the additive effect on discriminatory precision for the renal angina index on prediction of Day 3 - AKI (described in primary outcome)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5550</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Pediatric Intensive Care Unit Patients</arm_group_label>
    <description>All patients will be included in a single cohort initially (admission to the PICU) and then cohorted into groups based on renal angina risk strata, medical admission diagnoses, and outcomes (Day 3 - AKI, analyzed post-hoc)</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine samples will be collected from participating centers (pending local IRB approval)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All medical and surgical patients admitted to the pediatric intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than 90 days and up to 25 years old

          -  All medical and surgical patients admitted to the pediatric intensive care unit

        Exclusion Criteria:

          -  History of recent renal transplant or end stage kidney disease

          -  Post-surgical cardiac patients and patients following cardiac catheterization
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajit K Basu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stuart Goldstein, MD</last_name>
    <role>Study Director</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tara Terrell</last_name>
    <phone>513-803-3294</phone>
    <email>tara.terrell@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Holshouser</last_name>
    <phone>513-803-3295</phone>
    <email>patricia.holshouser@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Askenazi</last_name>
      <email>daskenazi@peds.uab.edu</email>
    </contact>
    <investigator>
      <last_name>David Askenazi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vivienne Newman, MD</last_name>
      <email>vnewman@mail.cho.org</email>
    </contact>
    <investigator>
      <last_name>Vivienne Newman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Sutherland, MD</last_name>
      <email>suthersm@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Sutherland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vince Faustino</last_name>
      <email>vince.faustino@yale.edu</email>
    </contact>
    <contact_backup>
      <last_name>Olja Couloures</last_name>
    </contact_backup>
    <investigator>
      <last_name>Vince Faustino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours/Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joshua Zaritsky, MD</last_name>
      <email>joshua.zaritsky@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Joshua Zaritsky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>All Children's Hospital of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francisco Flores, MD</last_name>
      <email>floresfx@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Francisco Flores, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Paden, MD</last_name>
      <email>matthew.paden@choa.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Paden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Brophy, MD</last_name>
      <email>patrick-brophy@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Brophy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Somers, MD</last_name>
      <email>michael.somers@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Somers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Selewski, MD</last_name>
      <email>dselewsk@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>David Selewski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helen DeVos Children's Hospital</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Hackbarth, MD</last_name>
      <email>richard.hackbarth@devoschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Richard Hackbarth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospitals and Clinics</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vimal Chadha, MD</last_name>
      <email>vchadha@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Vimal Chadha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vikas Dharnidharka</last_name>
      <email>vikasD@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Davis</last_name>
      <email>Davis_TK@kids.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vikas Dharnidharka</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Wong</last_name>
      <email>cwong@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Wong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cohen Children's Medical Center of NY</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Schneider, MD</last_name>
      <email>jschneide2@NSHS.edu</email>
    </contact>
    <investigator>
      <last_name>James Schneider</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fangming Lin</last_name>
      <email>fl2300@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Fangming Lin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook Long Island Children's Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Woroniecki, MD</last_name>
      <email>robert.woroniecki@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Woroniecki</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart Goldstein, MD</last_name>
      <email>stuart.goldstein@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Rajit Basu, MD</last_name>
      <email>rajit.basu@cchmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Stuart Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Myers</last_name>
      <email>David-Myers@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>David Myers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geoffrey Fleming, MD</last_name>
      <email>Geoffrey.fleming@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Fleming</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyssa Riley, MD</last_name>
      <email>riley@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ayse Arickan</last_name>
      <email>aaarikan@texaschildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Alyssa Riley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Angelo</last_name>
      <email>Joseph.R.Angelo@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Angelo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Angelo</last_name>
      <email>Joseph.R.Angelo@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Angelo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23284</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Bunchman, MD</last_name>
      <email>tbunchman@mcvh-vcu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Duane Wiliams</last_name>
    </contact_backup>
    <investigator>
      <last_name>Timothy Bunchman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital, Research, and Foundation</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jordan Symons, MD</last_name>
      <email>jordan.symons@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Jordan Symons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Sydney Children's Hospitals Network</name>
      <address>
        <city>Sydney</city>
        <zip>NSW 2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Alexander</last_name>
      <email>salexand8@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sean Kennedy</last_name>
      <email>Sean.Kennedy@SESIAHS.HEALTH.NSW.GOV.AU</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Alexander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto da Criança</name>
      <address>
        <city>Sao Paolo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vera Koch</last_name>
      <email>vkoch@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Vera Koch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Edmonton</name>
      <address>
        <city>Edmonton</city>
        <zip>AB T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Morgan, MD</last_name>
      <email>cmorgan@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Catherine Morgan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal Children's/McGill</name>
      <address>
        <city>Montreal</city>
        <zip>QC H3H 1P3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Zappitelli</last_name>
      <email>mzaprdr@yahoo.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Zappitelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of British Columbia and Children's and Women's Health Center of British Columbia Branch</name>
      <address>
        <city>Vancouver</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cherry Mammen</last_name>
      <email>cmammen@cw.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Cherry Mammen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanjing Children's Hospital</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Songming Huang</last_name>
      <email>smhuang@njmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Songming Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indraprastha Apollo Hospital</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shina Menon</last_name>
      <email>shinamenon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shina Menon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dept of Child Health Cipto Mangunkusumo/University of Indonesia</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eka Hidayati</last_name>
      <email>eka.laksmi@ui.ac.id</email>
    </contact>
    <investigator>
      <last_name>Eka Hidayati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dept of Child Health Airlangga University/Dr. Soetomo Hospital</name>
      <address>
        <city>Surabaya</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Risky Prasetyo</last_name>
      <email>kikiprasetyo14@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Noer N Soemyarso</last_name>
      <email>msnoer@pediatrik.com</email>
    </contact_backup>
    <investigator>
      <last_name>Risky Prasetyo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Pediatrico Bambino Gesu</name>
      <address>
        <city>Rome</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephano Picca</last_name>
      <email>stefano.picca@opbg.net</email>
    </contact>
    <investigator>
      <last_name>Stephano Picca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Children's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Il-Soo Ha</last_name>
      <email>ilsooha@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Hee Gyung Kang</last_name>
      <email>kanghg1@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Il-Soo Ha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Medical Institute, National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kar Hui</last_name>
      <email>kar_hui_ng@nuhs.edu.sg</email>
    </contact>
    <contact_backup>
      <last_name>Mya Than</last_name>
      <email>mya_than@nuhs.edu.sg</email>
    </contact_backup>
    <investigator>
      <last_name>Kar Hui</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Red Cross Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mignon McCullough</last_name>
      <email>mignon.mcculloch@uct.ac.za</email>
    </contact>
    <investigator>
      <last_name>Mignon McCullough</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>WC2R 2LS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akash Deep</last_name>
      <email>akash.deep@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Akash Deep, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>China</country>
    <country>India</country>
    <country>Indonesia</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
  </removed_countries>
  <link>
    <url>http://www.ppaki.org</url>
    <description>Website dedicated to pediatric AKI and has specific information about AWARE</description>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 9, 2014</lastchanged_date>
  <firstreceived_date>November 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Medical Center, Cincinnati</investigator_affiliation>
    <investigator_full_name>Rajit Basu, MD, F.A.A.P.</investigator_full_name>
    <investigator_title>Co-Director, Center for Acute Care Nephrology</investigator_title>
  </responsible_party>
  <keyword>Acute kidney injury</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Critical Care</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
